je.st
news
Home
› Ligand Pharmaceuticals' Shares Could Hit Triple Digits With Forward Guidance And 2015 Catalysts
Ligand Pharmaceuticals' Shares Could Hit Triple Digits With Forward Guidance And 2015 Catalysts
2015-05-16 22:15:01| Biotech - Topix.net
Ligand Pharmaceuticals , a favorite drug/biotech company of mine, recently reported its first quarter earnings. The strong earnings were enough to send shares up as high as $88.35 on Monday.
Tags: hit
forward
shares
guidance
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|